Muscle Spasm
📧 Sign up to get email alerts when something new happens for Muscle Spasm.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-11-08FDA Approved: CARISOPRODOL — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for carisoprodol by Rising Pharma Holdings, Inc., enabling the generic product to be marketed.
-
FDA approval · 2016-06-24FDA Approved: CHLORZOXAZONE — Original Application (Solubiomix)
FDA approves the Original Application for chlorzoxazone, a generic muscle relaxant manufactured by Solubiomix, for short-term relief of musc…
-
FDA approval · 2016-06-24FDA Approved: DIAZEPAM — Original Application (Chartwell Governmental & Specialty RX, LLC.)
FDA approved the original application for diazepam oral from Chartwell Governmental & Specialty RX, LLC. This marks approval of a generic di…
-
FDA approval · 2016-05-25FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for cyclobenzaprine hydrochloride from Amneal Pharmaceuticals of New York LLC. This update confi…
-
FDA approval · 2015-04-06FDA Approved: DIAZEPAM — Supplemental Application (Hospira, Inc.)
The FDA approved Hospira, Inc.'s supplemental application for diazepam (generic) under the ANDA.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-08-12FDA Approved: ROBAXIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Robaxin (methocarbamol) submitted by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2014-04-29FDA Approved: ROBAXIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Robaxin (methocarbamol) submitted by Hikma Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Evaluation of Eperisone HCl in the Treatment of Acute Musculoskeletal Spasm Associated With Low Back Pain - A Double Blind, Randomised, Placebo Controlled Clinical Trial [Phase 3]
A Phase 3 double-blind, randomized, placebo-controlled trial evaluating eperisone hydrochloride for acute musculoskeletal spasm associated w…
-
FDA approval · 2014-01-27FDA Approved: CARISOPRODOL — Original Application (Vensun Pharmaceuticals, Inc.)
The FDA approved an original ANDA for a generic carisoprodol manufactured by Vensun Pharmaceuticals, completing the generic entry for this m…
-
FDA approval · 2013-07-30FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for cyclobenzaprine hydrochloride from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2013-06-07FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for cyclobenzaprine hydrochloride from Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2013-04-30FDA Approved: CARISOPRODOL — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for carisoprodol by Rising Pharma Holdings, Inc., indicating an approved modification to the existin…
-
FDA approval · 2013-04-11FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (Solco Healthcare U.S., LLC)
FDA approves a supplemental application for Cyclobenzaprine Hydrochloride (Solco Healthcare U.S., LLC), authorizing the generic product to b…
-
FDA approval · 2013-04-11FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (SA3, LLC)
FDA approved a supplemental application for cyclobenzaprine hydrochloride (SA3, LLC), indicating approval of a supplemental submission for a…
-
FDA approval · 2013-04-11FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (KVK-TECH, Inc.)
FDA approved a supplemental application for cyclobenzaprine hydrochloride from KVK-Tech, Inc., allowing the generic product to proceed under…
-
FDA approval · 2013-04-11FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
The FDA approved a supplemental application for cyclobenzaprine hydrochloride (generic) from Jubilant Cadista Pharmaceuticals, approving an …
-
FDA approval · 2013-04-11FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for cyclobenzaprine hydrochloride from Rising Pharma Holdings, Inc., confirming approval of a generi…
-
FDA approval · 2013-04-11FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for cyclobenzaprine hydrochloride from Teva Pharmaceuticals USA, Inc., updating the existing approva…
-
FDA approval · 2013-02-01FDA Approved: SOMA — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Soma (carisoprodol) submitted by Viatris Specialty LLC.
-
FDA approval · 2013-01-31FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Original Application (Upsher-Smith Laboratories, LLC)
The FDA approved Upsher-Smith's generic cyclobenzaprine hydrochloride for use as a muscle relaxant in acute musculoskeletal conditions under…
-
FDA approval · 2012-09-28FDA Approved: METHOCARBAMOL — Supplemental Application (Solco Healthcare LLC)
FDA approved a supplemental application for methocarbamol from Solco Healthcare LLC.
-
FDA approval · 2011-08-30FDA Approved: ORPHENADRINE CITRATE — Original Application (Sagent Pharmaceuticals)
FDA approved Orphenadrine citrate under an Original Application for Sagent Pharmaceuticals.
-
FDA approval · 2011-02-28FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Original Application (KVK-TECH, Inc.)
FDA approved cyclobenzaprine hydrochloride from KVK-Tech under an original ANDA, enabling marketing of this generic muscle relaxant for acut…
-
FDA approval · 2010-03-30FDA Approved: ORPHENADRINE CITRATE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for orphenadrine citrate submitted by Sandoz Inc.
-
FDA approval · 2010-03-10FDA Approved: CARISOPRODOL — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Carisoprodol from Rising Pharma Holdings, Inc. The approval updates the regulatory status of thi…